Roka Bioscience Prominex Developing Rapid Point-of-Care MDx Using Novel Detection Tech Premium The technology works directly from clinical samples and can potentially be multiplexed to detect tens of targets, according to the firm. Roka Bioscience Sells Assets for $17.5M, Will Likely Liquidate The sale of assets to the Institute for Environmental Health comes after an extensive review of strategic alternatives for Roka, the company said. Roka Bio Q1 Revenues Rise 25 Percent Revenue growth was driven by a 26 percent increase in the number of pathogen detection tests sold. The total number of placed Atlas instruments ticked up to 54. Roka Bioscience Q4 Revenues Up 27 Percent The company said it had 53 of its Atlas molecular diagnostic systems placed with customers under commercial agreements as of the end of 2016. Roka Bioscience Q3 Revenues Up 27 Percent The company attributed the revenue growth to an increased number of its Atlas molecular pathogen detection instruments placed with customers. Oct 11, 2016 Roka Bioscience Plans 1-for-10 Reverse Stock Split Sep 16, 2016 Roka Bioscience Plans to Raise $22.5M in Private Placement Aug 5, 2016 Roka Bioscience Q2 Revenues Up 20 Percent May 4, 2016 Roka Bioscience Q1 Revenues Grow 7 Percent Mar 4, 2016 Roka Bioscience Q4 Revenues Rise 7 Percent Dec 15, 2015 MBio Dx, Roka Bio Ink Food Safety Product Development Deal Nov 11, 2015 Roka Bioscience Reports Flat Q3 Revenues Sep 23, 2015 Roka Bioscience Targets $100M Public Offering With Shelf Registration Aug 13, 2015 Roka Bio Revenues Grow 7 Percent in Q2 May 8, 2015 Roka Bioscience Posts 82 Percent Rise in Q1 Revenues Mar 26, 2015 Roka Bio Reports Doubling of Q4 Revenues Nov 6, 2014 Roka Bioscience Posts Jump in Q3 Revenues; Falls Short of Estimates Aug 15, 2014 In Brief This Week: Roka Bioscience, Hologic; Almac; Eurofins; Quest Diagnostics; Interleukin; and More Aug 11, 2014 Roka Bio Q2 Revenues More than Double; Leerink Initiates Coverage with Outperform Rating Jul 17, 2014 Roka Goes Public in $60M Stock Offering Jul 8, 2014 UPDATE: Roka Eyes Net Proceeds of $78M from Planned IPO May 22, 2014 Roka Bioscience Joins Growing List of MDx Firms Seeking an IPO Jan 20, 2012 In Brief This Week: Complete Genomics; MOgene, Fluidigm; Roka Bioscience; Silicon Kinetics; Precision Biosciences; IDBS Jan 12, 2012 Roka Bioscience Secures $47.5M Financing to Commercialize Food Testing Platform Premium Jan 6, 2012 Roka Bioscience Closes on $27.5M of Targeted $47.5M in Series D Round Load More Breaking News Agilent Technologies Fiscal Q2 Revenues Rise 5 Percent SARS-CoV-2 Genome Analysis Reveals Fitness-Enhancing Mutations Startup Incubator IndieBio, GP-Write Launch Initiative to Fund Genome Engineering Firms Precipio Receives CE-IVD Mark for Hematologic Cancer Panels Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection BioMérieux Gets Health Canada Approval for Updated BioFire Blood Culture ID Panel The Scan Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports. Vitamin D From Tomatoes According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D. Cause Not Yet Spotted NPR reports that a new study was unable to find a cause for persistent long COVID symptoms. PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.